| Oct 17 |
Genmab A/S (GMAB): Leading Innovation in Antibody Therapeutics
|
| Oct 16 |
Is the Options Market Predicting a Spike in Genmab (GMAB) Stock?
|
| Oct 16 |
12 Analysts Have This To Say About Genmab
|
| Oct 15 |
Is Genmab (GMAB) Stock Undervalued Right Now?
|
| Oct 15 |
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2024
|
| Oct 9 |
Genmab A/S (GMAB): Among The Stocks With Biggest Upside Potential According to Hedge Funds
|
| Oct 8 |
Down -14.68% in 4 Weeks, Here's Why Genmab Looks Ripe for a Turnaround
|
| Oct 8 |
GMAB or INCY: Which Is the Better Value Stock Right Now?
|
| Oct 8 |
Down -14.68% in 4 Weeks, Here's Why Genmab (GMAB) Looks Ripe for a Turnaround
|
| Oct 4 |
Major Shareholder Announcement
|
